Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Yang Wang, Qiukui Hao, et al.
The Lancet (2021) Vol. 399, Iss. 10321, pp. 259-269
Closed Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1498
Contemporary medical, device, and surgical therapies for obesity in adults
Carolina M. Perdomo, Ricardo V. Cohen, Priya Sumithran, et al.
The Lancet (2023) Vol. 401, Iss. 10382, pp. 1116-1130
Closed Access | Times Cited: 345
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Rexiati Ruze, Tiantong Liu, Xi Zou, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 304
Obesity Management in Adults
Arielle Elmaleh-Sachs, Jessica L. Schwartz, Carolyn T. Bramante, et al.
JAMA (2023) Vol. 330, Iss. 20, pp. 2000-2000
Open Access | Times Cited: 205
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Kailei Nong, Per Olav Vandvik, et al.
BMJ (2023), pp. e074068-e074068
Open Access | Times Cited: 161
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis
Yanjiao Shen, Qingyang Shi, Kailei Nong, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 3, pp. 1199-1211
Open Access | Times Cited: 139
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Eduardo Grunvald, Raj Shah, Rubén Hernáez, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1198-1225
Open Access | Times Cited: 126
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 96
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment
Sabrena Noria, Rita D. Shelby, Katelyn D. Atkins, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 3, pp. 31-42
Open Access | Times Cited: 91
New insights into the treatment of obesity
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 85
Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials
Omar S. Alkhezi, Abdullah A. Alahmed, Osamah M. Alfayez, et al.
Obesity Reviews (2022) Vol. 24, Iss. 3
Closed Access | Times Cited: 76
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Alexandro Chu, Melanie Wong, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1470-1492
Open Access | Times Cited: 54
Obesity in adults
Ildiko Lingvay, Ricardo V. Cohen, Carel W. le Roux, et al.
The Lancet (2024) Vol. 404, Iss. 10456, pp. 972-987
Closed Access | Times Cited: 52
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Yiming Mu, Xiao-lei Bao, Freddy G. Eliaschewitz, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 3, pp. 184-195
Closed Access | Times Cited: 36
Obesity and the kidney: mechanistic links and therapeutic advances
Kevin Yau, Rachel Kuah, David Z.I. Cherney, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 6, pp. 321-335
Closed Access | Times Cited: 28
Effectiveness and safety of drugs for obesity
Kristina H. Lewis, Caroline E Sloan, Daniel H. Bessesen, et al.
BMJ (2024), pp. e072686-e072686
Open Access | Times Cited: 21
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Obesity
Adam H. Gilden, Victoria A. Catenacci, John Michael Taormina
Annals of Internal Medicine (2024) Vol. 177, Iss. 5, pp. ITC65-ITC80
Closed Access | Times Cited: 18
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review
Bronya Calvarysky, I Dotan, Daniel Shepshelovich, et al.
Drug Safety (2024) Vol. 47, Iss. 5, pp. 439-451
Open Access | Times Cited: 16
Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Areesha Moiz, Jeremy Y. Levett, Kristian B. Filion, et al.
The American Journal of Cardiology (2024) Vol. 222, pp. 121-130
Open Access | Times Cited: 16
2024 Clinical practice guidelines for Hypertension in adults
Ж. Д. Кобалава, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 9, pp. 6117-6117
Open Access | Times Cited: 15
FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
Zarwa Idrees, Ivan Cancarevic, Li Huang
Cureus (2022)
Open Access | Times Cited: 55
Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Xueqin Gao, Xiaoli Hua, Xu Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
Huimin You, Yue Tan, Dawei Yu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 45
Current and novel treatment options for obstructive sleep apnoea
Winfried Randerath, Jan de Lange, Jan Hedner, et al.
ERJ Open Research (2022) Vol. 8, Iss. 2, pp. 00126-2022
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top